AbbVie share hit 5-year high with strong sales growth in fourth quarter
By Yanchun (Roxanne) Liu Medill Reports Stock of AbbVie Inc. (NYSE: ABBV) soared 13.8 percent, hitting a five-year high, after the North Chicago-based biopharmaceutical company reported Friday quarterly adjusted earnings that beat Wall Street expectations and strong growth in sales of flagship drug Humira. However, net earnings plunged 96.3 percent to $52 million, or 3 […]
